billHR7966Event Tuesday, March 17, 2026Analyzed

Hospice CARE Act of 2026

Neutral

Summary

HR7966 (Hospice CARE Act of 2026) proposes a 5-year nationwide moratorium on new Medicare hospice enrollment, but is in early legislative stages—referred to committee with only 2 cosponsors. No explicit funding, no near-term market impact. No public companies directly affected at this stage.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR7966 is an early-stage bill with no funding attached—near-term market impact is zero.
  • 2.Only 2 cosponsors, no scheduled markups, and identical companion bill just referred to the Senate Finance Committee.
  • 3.Existing hospice providers (no publicly traded pure plays of scale) would retain market positions; no ticker movement warranted.

Market Implications

No current market implications. The bill is procedural noise at this stage. If it advances out of committee, small-cap hospice operators and nursing home REITs with hospice exposure (e.g., $OHI, $WELL) would see minimal structural benefit from reduced new competition. No actionable information now.

Full Analysis

HR7966 was introduced on March 17, 2026, by Rep. Sánchez (D-CA) and referred to the House Committees on Ways and Means and Energy and Commerce. An identical companion bill, S4118, was introduced in the Senate. The bill is in early legislative stages—no hearings, markup, or floor votes scheduled. With only 2 cosponsors and procedural status, near-term passage probability is extremely low. The bill authorizes zero funding; it imposes a regulatory moratorium (a ban on new Medicare hospice provider enrollment for 5 years) with exemptions for underserved areas. No actual dollars are authorized or appropriated. No public companies are explicitly named or directly impacted by this bill at this stage. Hospice care is provided primarily by privately held entities and small regional nonprofits; public companies with hospice exposure (e.g., $CHE, $AMED) are not materially affected because the bill grandfathers existing providers and only halts new enrollment. If the bill advanced, it would structurally benefit existing providers by reducing competition, but at this procedural stage the market impact is negligible. Investors should monitor committee activity; no actionable trade signal currently exists.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

proclamationJul 13, 2026

Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security

President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).

Exec OrderJun 25, 2026

Advancing Regenerative Agriculture and Strengthening American Farm Resilience

This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.

Exec OrderJun 3, 2026

Implementing Schedule Policy/Career in the Excepted Service

This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →